Subscribe to RSS
DOI: 10.1055/s-0038-1676774
Bronchoscopic Lung Volume Reduction in Patients with Severe Emphysema
Publication History
Publication Date:
14 January 2019 (online)
Abstract
Bronchoscopic lung volume reduction (BLVR) is a minimally invasive procedure for patients with symptomatic severe emphysema who may not be candidates for surgical lung volume reduction. BLVR has been shown to improve both functional and clinical outcomes with a relatively low risk of severe complications. Any potential candidate to BLVR should be on optimal pharmacological and nonpharmacological treatment. Radiographic and pulmonary function testing provide key data to help identify potential BLVR candidates. A variety of BLVR techniques have been published with different associated benefits and risks. Current strategies include either blocking procedures such as endobronchial valves and intrabronchial valves or nonblocking procedures such as endobronchial coils and bronchoscopic thermal vapor ablation. The aim of this review is to describe current options of BLVR including their efficacy and safety based on available data.
-
References
- 1 Menezes AM, Perez-Padilla R, Jardim JR. , et al; PLATINO Team. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366 (9500): 1875-1881
- 2 Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available at: http://www.goldcopd.org/ 2018 . Accessed September 2, 2018
- 3 Horita N, Goto A, Shibata Y. , et al. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev 2017; 2: CD012066
- 4 Kew KM, Dias S, Cates CJ. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Cochrane Database Syst Rev 2014; (03) CD010844
- 5 Mulhall P, Criner G. Non-pharmacological treatments for COPD. Respirology 2016; 21 (05) 791-809
- 6 Chong J, Leung B, Poole P. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2017; 9: CD002309
- 7 Mineshita M, Slebos DJ. Bronchoscopic interventions for chronic obstructive pulmonary disease. Respirology 2014; 19 (08) 1126-1137
- 8 Gompelmann D, Herth FJ. Novel technologies in endoscopic lung volume reduction. Thorac Surg Clin 2016; 26 (02) 177-186
- 9 Puhan MA, Gimeno-Santos E, Cates CJ, Troosters T. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2016; 12: CD005305
- 10 Zephyr® Endobronchial Valve System - P180002. Available at: https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm614563.htm 2018 . Accessed September 16, 2018
- 11 Sciurba FC, Ernst A, Herth FJ. , et al; VENT Study Research Group. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363 (13) 1233-1244
- 12 Wood DE, Nader DA, Springmeyer SC. , et al; IBV Valve Trial Research Team. The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema. J Bronchology Interv Pulmonol 2014; 21 (04) 288-297
- 13 Shah PL, Gompelmann D, Valipour A. , et al. Thermal vapour ablation to reduce segmental volume in patients with severe emphysema: STEP-UP 12 month results. Lancet Respir Med 2016; 4 (09) e44-e45
- 14 Herth FJ, Noppen M, Valipour A. , et al; International VENT Study Group. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 2012; 39 (06) 1334-1342
- 15 Sciurba FC, Criner GJ, Strange C. , et al; RENEW Study Research Group. Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: the RENEW randomized clinical trial. JAMA 2016; 315 (20) 2178-2189
- 16 Deslée G, Mal H, Dutau H. , et al; REVOLENS Study Group. Lung volume reduction coil treatment vs usual care in patients with severe emphysema: the REVOLENS randomized clinical trial. JAMA 2016; 315 (02) 175-184
- 17 Herth FJF, Slebos DJ, Criner GJ, Shah PL. Endoscopic lung volume reduction: an expert panel recommendation - update 2017. Respiration 2017; 94 (04) 380-388
- 18 Fernández-Bussy S, Labarca G, Caviedes I, Mehta HJ, Jantz M, Majid A. Endoscopic lung volume reduction in advanced pulmonary emphysema: initial experience in Chile [in Spanish]. Rev Med Chil 2017; 145 (05) 667-672
- 19 Schuhmann M, Raffy P, Yin Y. , et al. Computed tomography predictors of response to endobronchial valve lung reduction treatment. Comparison with Chartis. Am J Respir Crit Care Med 2015; 191 (07) 767-774
- 20 Kontogianni K, Russell K, Eberhardt R. , et al. Clinical and quantitative computed tomography predictors of response to endobronchial lung volume reduction therapy using coils. Int J Chron Obstruct Pulmon Dis 2018; 13: 2215-2223
- 21 Gompelmann D, Eberhardt R, Slebos DJ. , et al. Diagnostic performance comparison of the Chartis System and high-resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction. Respirology 2014; 19 (04) 524-530
- 22 Herth FJ, Slebos DJ, Rabe KF, Shah PL. Endoscopic lung volume reduction: an expert panel recommendation. Respiration 2016; 91 (03) 241-250
- 23 Herzog D, Poellinger A, Doellinger F. , et al. Modifying post-operative medical care after EBV implant may reduce pneumothorax incidence. PLoS One 2015; 10 (05) e0128097
- 24 Choi M, Lee WS, Lee M. , et al. Effectiveness of bronchoscopic lung volume reduction using unilateral endobronchial valve: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 2015; 10: 703-710
- 25 Gompelmann D, Herth FJ, Slebos DJ. , et al. Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration 2014; 87 (06) 485-491
- 26 Ninane V, Geltner C, Bezzi M. , et al. Multicentre European study for the treatment of advanced emphysema with bronchial valves. Eur Respir J 2012; 39 (06) 1319-1325
- 27 Davey C, Zoumot Z, Jordan S. , et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet 2015; 386 (9998): 1066-1073
- 28 Klooster K, ten Hacken NH, Hartman JE, Kerstjens HA, van Rikxoort EM, Slebos DJ. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med 2015; 373 (24) 2325-2335
- 29 Valipour A, Slebos DJ, Herth F. , et al. Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study. Am J Respir Crit Care Med. 2016; Nov 1; 194 (09) 1073-1082
- 30 van Agteren JE, Hnin K, Grosser D, Carson KV, Smith BJ. Bronchoscopic lung volume reduction procedures for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2017; 2: CD012158
- 31 Kemp SV, Slebos DJ, Kirk A. , et al; TRANSFORM Study Team *. A multicenter randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J Respir Crit Care Med 2017; 196 (12) 1535-1543
- 32 Criner GJ, Sue R, Wright S. , et al. LIBERATE Study Group. A multicenter randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (LIBERATE). Am J Respir Crit Care Med 2018; 198 (09) 1151-1164
- 33 Gompelmann D, Benjamin N, Bischoff E. , et al. Survival after endoscopic valve therapy in patients with severe emphysema. Respiration 2018; 1-8
- 34 Wang Y, Lai TW, Xu F. , et al. Efficacy and safety of bronchoscopic lung volume reduction therapy in patients with severe emphysema: a meta-analysis of randomized controlled trials. Oncotarget 2017; 8 (44) 78031-78043
- 35 Eberhardt R, Gompelmann D, Schuhmann M. , et al. Complete unilateral vs partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema. Chest 2012; 142 (04) 900-908
- 36 Fernandez-Bussy S, Labarca G, Majid A. Endoscopic lung volume reduction by endobronchial coils: first report from Latin America. J Bronchology Interv Pulmonol 2018; 25 (01) e4-e6
- 37 Herth FJ, Eberhard R, Gompelmann D, Slebos DJ, Ernst A. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Ther Adv Respir Dis 2010; 4 (04) 225-231
- 38 Slebos DJ, Klooster K, Ernst A, Herth FJF, Kerstjens HAM. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest 2012; 142 (03) 574-582
- 39 Shah PL, Zoumot Z, Singh S. , et al; RESET trial Study Group. Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): a randomised controlled trial. Lancet Respir Med 2013; 1 (03) 233-240
- 40 Snell GI, Hopkins P, Westall G, Holsworth L, Carle A, Williams TJ. A feasibility and safety study of bronchoscopic thermal vapor ablation: a novel emphysema therapy. Ann Thorac Surg 2009; 88 (06) 1993-1998
- 41 Roetting M, Gompelmann D, Herth FJF. Thermic and chemical procedures for bronchoscopic lung volume reduction. J Thorac Dis 2018; 10 (Suppl. 23) S2806-S2810
- 42 Ramaswamy A, Puchalski J. Bronchoscopic lung volume reduction: recent updates. J Thorac Dis 2018; 10 (04) 2519-2527
- 43 Gompelmann D, Shah PL, Valipour A, Herth FJF. Bronchoscopic thermal vapor ablation: best practice recommendations from an expert panel on endoscopic lung volume reduction. Respiration 2018; 95 (06) 392-400
- 44 Herth FJ, Valipour A, Shah PL. , et al. Segmental volume reduction using thermal vapour ablation in patients with severe emphysema: 6-month results of the multicentre, parallel-group, open-label, randomised controlled STEP-UP trial. Lancet Respir Med 2016; 4 (03) 185-193